Related Experiment Video
Updated: Jan 27, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
Epithelial to Mesenchymal Transition and Cell Biology of Molecular Regulation in Endometrial Carcinogenesis
Hsiao-Chen Chiu1,2, Chia-Jung Li3, Giou-Teng Yiang4,5
1Department of Obstetrics and Gynecology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taipei 231, Taiwan. 97311141@gms.tcu.edu.tw.
Abstract:
Endometrial carcinogenesis is involved in several signaling pathways and it comprises multiple steps. The four major signaling pathways-PI3K/AKT, Ras/Raf/MEK/ERK, WNT/β-catenin, and vascular endothelial growth factor (VEGF)-are involved in tumor cell metabolism, growth, proliferation, survival, and angiogenesis. The genetic mutation and germline mitochondrial DNA mutations also impair cell proliferation, anti-apoptosis signaling, and epithelial⁻mesenchymal transition by several transcription factors, leading to endometrial carcinogenesis and distant metastasis. The PI3K/AKT pathway activates the ransforming growth factor beta (TGF-β)-mediated endothelial-to-mesenchymal transition (EMT) and it interacts with downstream signals to upregulate EMT-associated factors. Estrogen and progesterone signaling in EMT also play key roles in the prognosis of endometrial carcinogenesis. In this review article, we summarize the current clinical and basic research efforts regarding the detailed molecular regulation in endometrial carcinogenesis, especially in EMT, to provide novel targets for further anti-carcinogenesis treatment.
Insights
Endometrial carcinogenesis involves key signaling pathways like PI3K/AKT and WNT/β-catenin, driving tumor growth and metastasis. Understanding these molecular mechanisms, particularly epithelial-to-mesenchymal transition (EMT), offers new therapeutic targets for endometrial cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Endometrial carcinogenesis is a complex, multi-step process driven by aberrant signaling pathways.
- Key pathways implicated include PI3K/AKT, Ras/Raf/MEK/ERK, WNT/β-catenin, and vascular endothelial growth factor (VEGF).
- Genetic and mitochondrial DNA mutations contribute to uncontrolled cell proliferation, apoptosis resistance, and metastasis.
Purpose of the Study:
- To review current research on the molecular regulation of endometrial carcinogenesis.
- To specifically focus on the role of epithelial-to-mesenchymal transition (EMT) in endometrial cancer progression.
- To identify potential novel therapeutic targets for anti-carcinogenesis treatments.
Main Methods:
- Literature review of clinical and basic research.
- Analysis of molecular signaling pathways involved in endometrial cancer.
- Examination of the role of genetic mutations and hormonal signaling in carcinogenesis.
Main Results:
- The PI3K/AKT pathway, along with TGF-β, promotes endothelial-to-mesenchymal transition (EMT).
- EMT-associated factors are upregulated through interactions within these signaling cascades.
- Estrogen and progesterone signaling significantly influence EMT and endometrial cancer prognosis.
Conclusions:
- Detailed understanding of molecular mechanisms, especially EMT, is crucial for endometrial cancer treatment.
- Targeting specific signaling pathways and EMT processes may offer novel therapeutic strategies.
- Further research into these molecular targets holds promise for improving anti-carcinogenesis therapies.
Related Concept Videos
UV–Vis Spectroscopy: Molecular Electronic Transitions
Phase Transitions
Negative Regulator Molecules
Properties of Transition Metals
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Mesenchymal Stem Cells

